DrugPatentWatch Database Preview

EFFEXOR XR Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

Which patents cover Effexor Xr, and what generic alternatives are available?

Effexor Xr is a drug marketed by Upjohn and is included in one NDA.

The generic ingredient in EFFEXOR XR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Effexor Xr

A generic version of EFFEXOR XR was approved as venlafaxine hydrochloride by TEVA on August 3^rd, 2006.

Summary for EFFEXOR XR

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	113
Clinical Trials:	58
Patent Applications:	1,993
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for EFFEXOR XR
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for EFFEXOR XR
DailyMed Link:	EFFEXOR XR at DailyMed

See drug prices for EFFEXOR XR

See drug sales revenues for EFFEXOR XR

Recent Clinical Trials for EFFEXOR XR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of California, San Diego	Phase 2
Pfizer	N/A
Reckitt Benckiser LLC	Phase 1/Phase 2

See all EFFEXOR XR clinical trials

Pharmacology for EFFEXOR XR

Drug Class	Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of Action	Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for EFFEXOR XR

N06AX	Other antidepressants
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

Paragraph IV (Patent) Challenges for EFFEXOR XR

Tradename	Dosage	Ingredient	NDA	Submissiondate
EFFEXOR XR	CAPSULE, EXTENDED RELEASE;ORAL	venlafaxine hydrochloride	020699	2007-05-03

US Patents and Regulatory Information for EFFEXOR XR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Upjohn	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-001	Oct 20, 1997	AB	RX	Yes	No
Upjohn	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-004	Oct 20, 1997	AB	RX	Yes	Yes
Upjohn	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-002	Oct 20, 1997	AB	RX	Yes	No

Expired US Patents for EFFEXOR XR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Upjohn	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-001	Oct 20, 1997
Upjohn	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-003	Oct 20, 1997
Upjohn	EFFEXOR XR	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020699-003	Oct 20, 1997

International Patents for EFFEXOR XR

Country	Patent Number	Estimated Expiration
Estonia	200000212
China	1164389
Turkey	9700190

Supplementary Protection Certificates for EFFEXOR XR

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0112669	96C0002	Belgium		PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622